Nachrichten zur Johnson & Johnson Aktie

2 Unstoppable Dividend Stocks to Buy Now With $500

Whether you prefer growth stocks, value stocks, dividend stocks, or a mixture of investments in your portfolio, price should only…

2 Dow Jones Dividend Stocks With Yields Above 3% You Can Buy Now and Hold at Least a Decade

If you have any faith in economic indicators, right now seems like a terrible time to buy stocks. A long…

Heres Why You Should Avoid Investing in Johnson Controls Now

Weakness in the Building Solutions Asia Pacific segment and increasing expenses weigh on JCI. Unfavorable foreign currency movement is an…

Heres Why You Should Avoid Investing in Johnson Controls Now

Weakness in the Building Solutions Asia Pacific segment and increasing expenses weigh on JCI. Unfavorable foreign currency movement is an…

Dr. Oz Held Millions In Healthcare Investments, Raising Potential Conflicts For Medicare And Medicaid

The celebrity doctor’s 2022 financial disclosure for his Senate run details holdings in stocks like UnitedHealth, CVS and Johnson &…

J&J, Merck Cut Jobs in China as Local Competition Takes Toll

Johnson & Johnson and Merck & Co. are cutting jobs in China, as they face growing competition from domestic rivals…

Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive

…

Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)

…

Should You Buy the 3 Highest Paying Dividend Stocks in the Dow Jones?

High dividend yields can be a warning sign for investors. Yields generally correlate negatively with stock price movements, after all,…

Johnson Controls Boosts AI Capabilities in OpenBlue Digital Ecosystem

JCI boosts the AI capabilities in its OpenBlue Enterprise Manager suite, introducing generative AI applications, improved building controls and an…

Johnson & Johnson: Tracking Well Above The Industry

…

Johnson Controls Q4: Strong Order Growth Led By Data Center

…

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma

If approved, daratumumab will become the first treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple…

Lincoln Tech and Johnson Controls Partnership Delivers Over 500 Skilled Building Trade Hires Nationwide Since 2018

PARSIPPANY, NJ – November 7, 2024, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (NASDAQ: LINC),…

Johnson Controls Q4 Earnings Surpass Estimates, Revenues Miss

JCIs fiscal fourth-quarter results benefit from strength in the HVAC & controls businesses.…

Why Johnson Controls Stock Raced Nearly 9% Higher Today

The company exceeded analyst projections on both its top and bottom lines in its latest completed quarter.…

Lumen CEO on tech partnerships, Google Cloud deal and future of AI

Kate Johnson, Lumen CEO, joins Closing Bell: Overtime to discuss the companys tech partnerships, Google Cloud deal and AI.…

The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction

mazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.…

Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific

Todays Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and…

Johnson Outdoors: More Discipline Required

…

If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Johnson & Johnson (NYSE:JNJ) researches, develops, manufactures and sells various products in the health care field worldwide. It is set…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock @themotleyfool #stocks $JNJ $LLY $BIIB

Fewer contenders means fewer constraints on expanding market share.…

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lillys Stock

Fewer contenders means fewer constraints on expanding market share.…

Johnson & Johnson Aktie: MedTech hat Rückenwind

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi are included in this Analyst Blog.…

Kenvue shares surge after activist Starboard takes stake

Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023.…

Johnson & Johnson Aktie: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Joanne Wuensch, Analystin der Citigroup, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN:…

Passives Einkommen: Zuverlässige Dividendenerträge? Hier sind Anleger bestens aufgehoben!

Kaum ein Unternehmen schüttet so sicher Dividenden aus wie Johnson & Johnson. Und seit 62 Jahren steigen sie kontinuierlich und…

Investigation underway into leak of US intelligence on Israel-Iran, Houses Johnson says By Reuters

Investigation underway into leak of US intelligence on Israel-Iran, Houses Johnson says…

Johnson & Johnson: Q3 Earnings Highlights Resilience And New Growth

…

Johnson & Johnson Aktie: Kurszielerhöhung nach starkem Q3-Ergebnis

Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital Markets hat das Kursziel für Johnson &…

Johnson & Johnson Q3 Earnings Review: Nicely Poised For Steady Growth (Upgrade)

…

This Magnificent Dividend Stock Is as Healthy as It Gets @themotleyfool #stocks $JNJ

Johnson & Johnsons latest financial checkup shows its still in excellent health.…

Johnson & Johnson Aktie: Pharma-Sparte übertrifft Erwartungen - Kursziel angehoben!

New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley: Morgan Stanley erhöht Kursziel auf 175 USD Der Analyst Terence Flynn von…

ETFs in Focus Post JNJ Q3 Earnings Beat, Target Price Hike

Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their target price on…

J&J Talc Settlement Holdouts Accuse Company of Buying Votes

People who voted to settle their baby power-related health claims against Johnson & Johnson should have their ballots thrown out…

Verhaltene Kauflaune bei Johnson & Johnson-Aktie (151,4853 €)

Am US-amerikanischen Aktienmarkt ist der Anteilsschein von Johnson & Johnson aktuell unauffällig. Das Papier kostete zuletzt 164,46 US-Dollar. Kaum auffällig…

J&J überzeugt mit starkem Umsatz im 3. Quartal! Gewinnprognosesenkung und Talkumpuderprozess belasten den Kurs

Der Pharma- und Medizintechnikhersteller Johnson & Johnson (JNJ) hat am Dienstag, den 15. Oktober 2024 seine Geschäftszahlen für das…

Johnson & Johnson Aktie: Solide Geschäftsfundamente - Kursziel angehoben!

St. Louis (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Stifel: Stifel hat das Kursziel für Johnson & Johnson (ISIN: US4781601046, WKN: 853260,…

Johnson & Johnson Aktie: Optimistischer Ausblick für 2025 trotz verhaltener Q4-Wachstumsprognose

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors: Wells Fargo hat das Kursziel für Johnson & Johnson (ISIN:…

Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript

JNJ earnings call for the period ending September 30, 2024.…

Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript

…

Johnson & Johnson Q3: Strengthening Cardiovascular Device Portfolio

…

4 stocks to watch on Tuesday: BAC, JNJ and more

Bank of America (BAC), Goldman Sachs (GS), Johnson & Johnson (JNJ) and UnitedHealth (UNH) are the stocks to watch on…

Bank earnings, Nvidia record high, oil prices sink: 3 Things

US stock futures (ES=F, NQ=F, YM=F) are flat Tuesday morning coming off the Dow Jones Industrial Average (^DJI) and S&P…

J&J beats Q3 earnings estimates, raises full-year sales guidance

Johnson & Johnson (NYSE:JNJ) shares moved higher after the pharmaceutical giant posted better-than-expected results for the third quarter. Earnings per...…

Johnson & Johnsons Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition

…

dpa-AFX ProFeed